Standards for All: Controlling Your Metadata for Vendors, Study Sites, and Submission Datasets On-Demand Webinar Standards for All: Controlling Your Metadata for Vendors, Study Sites, and Submission Datasets Director of Product, Certara's Pinnacle 21Senior Principal CDISC Consultant, Certara's Pinnacle 21Achieve submission ready conformance…Certara2025年2月7日
Best Practices for International Pharma Content Roll-Out Blog Best Practices for International Pharma Content Roll-Out 2025年1月31日 Pharmaceutical market access, sales, and field teams rely on high-quality, effective content…Certara2025年1月31日
How to Validate Your Clinical Data Using FDA Validation Rules Blog FDAのバリデーションルールを用いた臨床データのバリデーション方法 2025年1月30日 For clinical data managers, understanding clinical data validation and applying FDA validation…Certara2025年1月30日
Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research Webinar Phoenix Hosted: よりスマートでスピーディーな研究のための クラウド版 PK/PD解析ソフトウェア Certara2025年1月30日
Transforming Perspectives: 25 Years of PBPK Modeling in Drug-Drug Interactions On-Demand Webinar Transforming Perspectives: 25 Years of PBPK Modeling in Drug-Drug Interactions Vice President and Head of Global PK/PD and Pharmacometrics at Eli Lilly and Company Dr.…Certara2025年1月29日
The Benefits of Real-Time Nonclinical Safety Data Analysis White Paper The Benefits of Real-Time Nonclinical Safety Data Analysis Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…Certara2025年1月27日
Achieve Clinical Data Transparency with the 4 Cs of Collaboration Blog Achieve Clinical Data Transparency with the 4 Cs of Collaboration In this blog, we look at how you can enhance clinical data transparency and make…Certara2025年1月15日
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease Publication INTERCEPT-AD:アルツハイマー病による軽度認知障害または軽度認知症の被験者を対象とした、サビルネトゥグ静脈内投与のフェーズ1試験 The Phase 1 INTERCEPT-AD study evaluated sabirnetug (ACU193), a monoclonal antibody targeting amyloid-beta oligomers (AβOs),…Certara2025年1月8日
Where to Start? Setting Your Medical Writing Team Up for Success with GenAI On-Demand Webinar Where to Start? Setting Your Medical Writing Team Up for Success with GenAI Generative AI (GenAI) is poised to revolutionize writing and report generation. In fact, industry studies…Certara2025年1月6日
Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development Video Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development At the 2024 AAPS PharmSci 360 conference, Bioanalysis Zone interviewed Piet van der Graaf, Senior…Certara2024年12月10日